Industry Collaboration and Membership - Accumulus Synergy welcomes CSL as its first member organization, marking significant progress in advancing critical therapies globally [1] - The membership model aims to shape regulatory policy, raise awareness of global harmonization, and drive digital transformation to accelerate therapies worldwide [2] - Membership is open to life sciences organizations, health associations, private/non-profit foundations, and other institutions, offering access to resources, thought leadership, and networking opportunities [4] Strategic Vision and Impact - Accumulus Synergy is described as a catalyst for change, pioneering an industry paradigm shift for regulatory harmonization and digital transformation [3] - The collaboration between Accumulus and CSL is expected to amplify their collective impact and drive positive change on a global scale [2] - The focus is on advancing opportunities for regulatory data convergence, data harmonization, and digital transformation [5] Company Overviews - Accumulus Synergy is a global nonprofit industry association developing a transformative data exchange platform to enhance collaboration between life sciences organizations and global Regulatory Authorities [6] - CSL is a global biotechnology company with a portfolio of lifesaving medicines, vaccines, and therapies, operating in over 100 countries with 32,000 employees [7] Media Contact - Media inquiries can be directed to Allison Mari at Accumulus Synergy [8]
CSL Joins Accumulus Synergy to Drive Industry Change